Abstract:Different methods of incorporating esterified [3H]cholesterol into human high density lipoproteins (HDL) have been assessed in terms of their influence on the subsequent rate at which esterified [3H]cholesterol was transferred from HDL to other plasma lipoproteins in 37 degrees C incubations containing tracer amounts of the labelled preparations added to aliquots of a common pool of unlabelled human plasma. Two basic methods were used to label the HDL esterified cholesterol: (a) by the action of lecithin: cholesterol acyltransferase in incubations of plasma containing exogenous [3H]cholesterol and (b) by exchange in incubations of plasma containing preparations of prelabelled LDL. The exchange labelling approach was also used to examine the effects of various HDL compositional changes on the subsequent behaviour of its esterified [3H]cholesterol. It was found that the source of the label, per se, whether from the esterification of exogenous [3H]cholesterol or from exchange with labeled LDL, had no influence on the subsequent behaviour of HDL esterified [3H]cholesterol. However, modification of the HDL composition during the labelling process had profound effects. For example, in preparations in which the esterified cholesterol content of the labelled HDL was increased by the action of lecithin: cholesterol acyltransferase, there was a reduced rate of transfer of esterified [3H]cholesterol out of the HDL fraction in subsequent incubations of the labelled HDL with fresh, unlabelled plasma. Conversely, when the esterified cholesterol content of the labelled HDL had been decreased by pre-incubation with Intralipid or very low density lipoproteins (VLDL), the subsequent rate of transfer of esterified [3H]cholesterol out of the HDL fraction was increased markedly. It has been concluded that to obtain a biologically valid, labelled tracer of human HDL esterified cholesterol, the labelling should be achieved with minimal modification to the HDL composition. This means labelling by exchange in incubations in which lecithin: cholesterol acyltransferase is inhibited in plasma from which VLDL has been removed.

Function of PEGylated Cholesterol Esterase in the Homogeneous Assay of High Density Lipoprotein Cholesterol

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Effect of the nonenzymatic glycosylation of high density lipoprotein-3 on the cholesterol ester transfer protein activity

Effect of PEG Spacer on Cellulose Adsorbent for the Removal of Low Density Lipoprotein-Cholesterol.

The Chromatographic Behaviour of PEGylated Protein on Cation-Exchangers

A Simple and Precise Method to Detect Sterol Esterification Activity of Lecithin/cholesterol Acyltransferase by High-Performance Liquid Chromatography

Discarded free PEG-based assay for obtaining the modification extent of pegylated proteins

A simple and precise method for direct measurement of fractional esterification rate of high density lipoprotein cholesterol by high performance liquid chromatography

Cholesteryl Ester Transfer Protein Concentrations in Subjects with Various Dyslipidaemias

Site-Directed Modification of Genetically Engineered Proteus Sp Lipase K107 Variants with A Polyethylene Glycol Derivative

An Assay for Immunogenic Detection of Anti‐PEG Antibody

Enhanced activity of Candida rugosa lipase modified by polyethylene glycol derivatives

Cholesteryl Ester Transfer Protein Penetrates Lipoproteins for Cholesteryl Ester Transfer

Discovery of Pentacyclic Triterpene 3Β-Ester Derivatives As a New Class of Cholesterol Ester Transfer Protein Inhibitors.

Comparison of different methods of isotopically labelling the esterified cholesterol in human high density lipoproteins

Profiling of Cholesteryl Esters by Coupling Charge-Tagging Paternò–Büchi Reaction and Liquid Chromatography–Mass Spectrometry

Residue profiles of peptides with cholesterol esterase and pancreatic lipase inhibitory activities through virtual screening and sequence analysis

A new mechanism of enantioselectivity towards chiral primary alcohols via study of chemical modification of lipase from Pseudomonas cepacia

Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin

Recent Development of Poly(ethylene Glycol)-Cholesterol Conjugates As Drug Delivery Systems